4//SEC Filing
Galson Steven K 4
Accession 0001171843-25-003912
CIK 0000882796other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:19 PM ET
Size
16.2 KB
Accession
0001171843-25-003912
Insider Transaction Report
Form 4
Galson Steven K
Director
Transactions
- Award
Common Stock
2025-06-12+12,500→ 24,991 total - Award
Automatic Stock Option Grant
2025-06-12+27,181→ 27,181 totalExercise: $10.40From: 2026-06-12Exp: 2035-06-12→ Common Stock (27,181 underlying)
Holdings
- 45,880(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- [F2]On July 16, 2024 and October 2, 2024, the Reporting Person transferred 12,600 and 11,340 shares, respectively, to a living trust for no consideration. The Reporting Person is an indirect beneficial owner of the shares held by the trust.
- [F3]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001495328
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:19 PM ET
- Size
- 16.2 KB